secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2026-06-04T11:54:06+00:00
Accession:  0001665988-26-000035
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus stockholders elect all 12 director nominees and ratify Grant Thornton as auditor at 2026 annual meeting
--------------------------------------------------------------------------------

- All 12 director nominees elected; votes-for ranged from 61.7M (Sutter) to 68.5M (Dhankhar).
- Stockholders ratified Grant Thornton LLP as independent auditor for FY 2026 with 75.2M votes in favor.
- Approximately 90.23% of outstanding shares (75.3M shares) were represented at the meeting.
- Director Martin P. Sutter received 6.8M withheld votes, more than any other nominee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000166598826000035/0001665988-26-000035-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000166598826000035/bvs-20260603.htm
  HTML page:      https://secwatch.observer/filing/0001665988-26-000035

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer